| 1081/1507 | US=9 / Radioterapia Gorty S, Tripuraneni P. Practical clinical applications: techniques of intravascular brachytherapy. In: Levitt SH, Purdy JA, Perez CA, Vijayakumar S. Technical basis of radiation therapy: pratical clinical applications. 4th ed rev. New York: Spriger, 2008. p. 837-41. (Medical radiology: diagnosis imaging and radiation oncology series editors; AL Baert, LW Brady, HP Heilmann, M Molls, K Sartor) ISBN 978-3-540-21338-3. |
| 1082/1507 | US=90 / Biol/Mol Burgess AW, Garrett TPJ. EGFR signaling networks: EGF receptor family extracellular domain structures and functions. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 3-14. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. ERBB2; ERBB3; ERBB4; 3-DIMENSIONAL ESTRUTURAS; TRANSICOES CONFORMACIONAIS; EPITOPOS DE ANTICORPOS |
| 1083/1507 | US=90 / Biol/Mol Stern HM. EGFR signaling networks: EGFR family heteroimers in cancer pathogenesis and treatment. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 15-30. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. |
| 1084/1507 | US=90 / Biol/Mol Eigenbrot C. EGFR signaling networks: structure-function of EGFR kinase domain and its inhibitors. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 31-45. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. CRISTALOGRAFIA DE RAIOS X; INIBIDOR DE MOLECULA PEQUENA; ESCAPAR MUTACAO; ACTIVACAO DA CINASE; ALLOSTERY; L858R; T790M |
| 1085/1507 | US=90 / Biol/Mol Sorkin A. EGFR signaling networks: internalization and degradation of the EGF receptor. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 47-61. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. EGF; RECEPTOR; ENDOCITOSE; CLATRINA; UBIQUITINACAO; DEGRADACAO; ENDOSSOMO; LISOSSOMA |
| 1086/1507 | US=90 / Biol/Mol Xu W, Neckers L. EGFR signaling networks: differential dependence of EGFR and ErbB2 on the molecular chaperone Hsp90. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 63-71. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. CHAPERONES MOLECULARES; PROTEINA DE CHOQUE TERMICO 90; ANSAMICINAS BENZOQUINONA; GELDANAMICINA; HSP90 INIBIDOR; MUTACOES DE EGFR; SENSIBILIDADE AO FARMACO |
| 1087/1507 | US=90 / Biol/Mol Koppikar P, Grandis JR. EGFR signaling networks: activation of STATs 3 and 5 through the EGFR signaling axis. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 73-87. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. |
| 1088/1507 | US=90 / Biol/Mol Wislez M, Kurie JM. EGFR signaling networks: the intersection of EGFR and the Ras signaling pathway. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 89-95. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. |
| 1089/1507 | US=90 / Biol/Mol Domin J. EGFR signaling networks: phosphoinositide 3-kanase enzymes as downstrem targets of the EGF receptor. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 97-117. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. AKT; FATOR DE CRESCIMENTO EPIDERMICO; RECEPTOR; QUINASE; FOSFATIDILINOSITOL; TRANSDUCAO DE SINAL; CELULA; CANCER; MITOGENESE; APOPTOSE; ENDOCITOSE |
| 1090/1507 | US=90 / Biol/Mol Pritchard JE, Jablonski AB, Parsons SJ. EGFR signaling networks: convergence of EGF receptor and Src family signaling networks in cancer. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 119-37. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. |
| 1091/1507 | US=90 / Biol/Mol Gavard J, Gutkind JS. EGFR signaling networks: a molecular crosstalk between e-cadlherin and EGFR signaling networks. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 139-54. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. EGFR; JUNCOES CELULARES; ADESAO CELULAR; CADERINA; CATENINA MIGRACAO; ACTINA |
| 1092/1507 | US=90 / Biol/Mol Becker MA, Yee D. EGFR signaling networks: crosstalk between insulin-like growth factor (IGF) and epidermal growth factor (EGF) receptors. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 155-68. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. |
| 1093/1507 | US=90 / Biol/Mol Carraway KL, Yen L, Ingalla E, Sweeney C. EGFR signaling networks: negative regulation of signaling by the EGFR family. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 169-86. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. RECEPTOR EGF; CANCER DE MAMA; ERBB2; REGULADOR NEGATIVO; UBIQUITINA LIGASE E3; CAMUNDONGOS TRANSGENICOS |
| 1094/1507 | US=90 / Biol/Mol Lao HJ, Carpenter G. EGFR signaling networks: nuclear ErbB receptors: pathways and functions. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 187-97. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. ERBB; FATOR DE CRESCIMENTO EPIDERMICO; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; NUCLEO; SINALIZAR; TRANSDUCAO |
| 1095/1507 | US=90 / Biol/Mol Blagoev B, Kratchmarova I, Olsen JV, Mann M. EGFR signaling networks: temporal dynamics of EGF receptor signaling by quantitative proteomics. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 199-207. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. FATOR DE CRESCIMENTO EPIDERMICO; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; NUCLEO; SINALIZAR; TRANSDUCAO |
| 1096/1507 | US=90 / Biol/Mol Johnson CG, McIntyre E, Gullick W. EGFR signaling networks: computational and mathematical modeling of the EGF receptor system. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 209-18. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. |
| 1097/1507 | US=90 / Biol/Mol Normanno N, Bianco C, De Luca A, Strizzi L, Gallo M, Mancino M, Salomon DS. EGFR in tumorigenesis and EGFR tyrosine kinase inhibitors in cancer therapy: expression and prognostic significance of the EGFR in solid tumors. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 221-34. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. EGFR; ERBB2; ERBB3; ERBB4; EGF-COMO FATOR DE CRESCIMENTO; CANCER; PROGNOSTICO |
| 1098/1507 | US=90 / Biol/Mol Bennett HL, Brummer T, Timpson P, Patterson KI, Daly RJ. EGFR in tumorigenesis and EGFR tyrosine kinase inhibitors in cancer therapy: signaling by the EGF receptor in human cancers: accentuate the positive, eliminate the negative. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 235-55. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. SRC; RAS; RAF; ERK; PI3-QUINASE; PTEN; EGFR INIBIDORES; LOOPS DE FEEDBACK; C-CBL; ENDOCITOSE |
| 1099/1507 | US=90 / Biol/Mol Box C, Peak J, Rogers S, Eccles S. EGFR in tumorigenesis and EGFR tyrosine kinase inhibitors in cancer therapy: EGFR signaling in invasion, angiogenesis and metastasis. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 257-76. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. INVASAO; ADESAO; MOTILIDADE; PROTEOLISE; ANGIOGENESE; LINFANGIOGENESE; METASTASE |
| 1100/1507 | US=90 / Biol/Mol Wikstrand CJ, Bigner DD. EGFR in tumorigenesis and EGFR tyrosine kinase inhibitors in cancer therapy: constitutive activation of truncated EGF receptors in glioblastoma. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 277-92. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. AMPLIFICACAO DO GENE; IMUNOTERAPIA; MUTACAO; NEOPLASIAS DO SISTEMA NERVOSO; TRANSDUCAO DE SINAL |